Drug companies have been courting doctors for years, with trinkets, luxury trips, and cash. It’s not uncommon for doctors to earn big bucks speaking in favor of one drug or another (of course we mean name brands). And antidepressants are high on that list. Considering the questionable effectiveness, and the even more shaky science behind these highly over-prescribed drugs, and you can only imagine why pharmaceutical courting exists.
Here is the problem: When doctors are paid by a pharmaceutical company–like Wyeth, makers of Effexor, let’s say–then do you think those doctors will recommend any other option? When full-on seminars are sponsored by drug companies, do you think that most attendees will be prescribing Effexor like crazy on Monday? Do you think drug companies will place their product in anything but the most positive light? That’s exactly how drugs like Prozac, Luvox, Paxil, Celexa, Lexapro, and Zoloft received black box warnings after they had been on the market for several years, despite the fact that research showed a hightened risk for violence and suicidal tendencies in children. Do you think the manufacturers of these drugs disclosed these very important findings to their seminar attendees?
But once again, thank goodness some doctors and medical groups like the APA see the inherent problem. As former editor of the New England Journal of Medicine, Dr. Marcia Angell, says,
“It is self-evidently absurd to look to a company for information about a product it makes. Why can’t doctors, who are among the most privileged members of society, pay for their own continuing medical education? Why have they abdicated that responsibility to the companies who make drugs?”
And for those doctors who think they are above being persuaded, Dr. Angell adds,
“There are still those who feel strongly that they can hear things but it doesn’t influence their practice. But the evidence points the other way.”